Abiopharma

🔍 McNeil Joseph David (Executive)

Company: Weave Communications, Inc. (WEAV)

Report Date: 2026-03-26

Detailed Transactions and Holdings:

• Acquired 300,000 shares of Common Stock (Direct)
  Date: 2026-03-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 771,480.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 33% of the total number of shares on March 1, 2027, and the remainder in equal quarterly installments over the two years thereafter, until such time as the RSU is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.